WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease
VANCOUVER, BC and TORONTO, July 17, 2024 /PRNewswire/ – WELL Health Technologies Corp. (TSX:WELL) (OTCQX: WHTCF) (“WELL” or the “Company“) a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI Inc. (TSX:AIDX) (OTCQX: HWAIF) (“HEALWELL“), a healthcare technology company focused on AI and data science for preventative care, are jointly pleased to announce the launch of WELL’s AI-powered co-pilot for cardiologists exclusively powered by HEALWELL AI, aimed at identifying patients at high risk of cardiovascular disease (“CVD“). This significant expansion of WELL’s AI capabilities builds on the success of its second-generation AI-powered physician co-pilot, WELL AI Decision Support (“WAIDS“), developed exclusively in partnership with HEALWELL. This enhancement adds to its existing rare and chronic disease detection abilities and is an extension to the WAIDS offering.
Related news for (WHTCF)
- WELL HEALTH TECHNOLOGIES CORP. EARLY WARNING NEWS RELEASE
- WELL Health Reports Record Results for Q2-2024 Driven by an Acceleration in Organic Growth and Raises Annual Guidance
- WELL Health’s Circle Medical Provides Corporate Update, Exceeds $100M USD Revenue Run Rate with Profitability and Positions for Further Growth
- WELL Health Announces Approval for Historic $44M Project, the Largest DIGITAL Project Ever Awarded to Advance AI-powered Tech Enablement for Care Providers